Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>Events>This Event
  Events - June 2014

2nd Annual Discovery Chemistry & Drug Design Congress 2014

02 Jun 2014 - 03 Jun 2014 - Geneva, Switzerland

Bookmark and Share

Oxford Global Conferences are pleased to announce the 2nd Annual Discovery Chemistry & Drug Design Congress, taking place at the Intercontinental Geneva on 2 & 3 June 2014. This two day congress has been developed to offer discovery chemistry leaders an executive platform for networking and discussion. Our expert speakers will discuss methods of improving solubility, drugability and potency, while combatting the challenges of an increased demand for molecular complexity. Delegates will hear case studies covering a range of topics, including fragment based discovery, computer aided design for biologics and the role of natural products in discovery chemistry. The congress is part of the 15th Annual Drug Discovery Summit – Europe’s premier networking and discussion forum for pharmaceutical leaders. The congress is also co-located with the 6th Annual Drug Development Congress, a two day event focused on predictive science and translational medicine. Contact Danielle Dalby for more information on attendance, prices or to download the agenda on

Further information
Scientific News
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Mathematical Model Forecasts the Path of Breast Cancer
Chances of survival depend on which organs breast cancer tumors colonize first.
Exploring the Causes of Cancer
Queen's research to understand the regulation of a cell surface protein involved in cancer.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
RNA-Based Drugs Give More Control Over Gene Editing
CRISPR/Cas9 gene editing technique can be transiently activated and inactivated using RNA-based drugs, giving researchers more precise control in correcting and inactivating genes.
University of Glasgow Researchers Make An Impact in 60 Seconds
Early-career researchers were invited to submit an engaging, dynamic and compelling 60 second video illuminating an aspect of their research.
Metabolic Profiles Distinguish Early Stage Ovarian Cancer with Unprecedented Accuracy
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
Dead Bacteria to Kill Colorectal Cancer
Scientists from Nanyang Technological University (NTU Singapore) have successfully used dead bacteria to kill colorectal cancer cells.
CRISPR-Cas9 Gene Editing: Check Three Times, Cut Once
Two new studies from UC Berkeley should give scientists who use CRISPR-Cas9 for genome engineering greater confidence that they won’t inadvertently edit the wrong DNA.
Genetically Engineering Algae to Kill Cancer Cells
New interdisciplinary research has revealed the frontline role tiny algae could play in the battle against cancer, through the innovative use of nanotechnology.
Scroll Up
Scroll Down

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos